David Hägg
Impact in
- Immunology top 10%
- Psoriasis: Treatment and Pathogenesis
- Pharmacology top 10%
- Treatment of Major Depression
- Drug-Induced Hepatotoxicity and Protection
Papers in
-
- Psoriasis: Treatment and Pathogenesis 6
-
- Treatment of Major Depression 4
- Drug-Induced Hepatotoxicity and Protection 2
- Co-authors
- Anders Sundström (4 shared papers)Marcus Schmitt‐Egenolf (4 shared papers)Marie Eriksson (3 shared papers)Johan Reutfors (6 shared papers)Lena Brandt (5 shared papers)Philip Brenner (4 shared papers)Allitia DiBernardo (2 shared papers)Robert Bodén (2 shared papers)
- Journals
- Journal of Affective Disorders (2 papers)Clinical Epidemiology (2 papers)PLoS ONE (2 papers)CNS Drugs (1 paper)JAAD International (1 paper)
- Partner nations
- SwedenUnited StatesDenmark
In The Last Decade
David Hägg
16 papers receiving 485 citations
Peers
Comparison fields: 5 of 57
- Immunology 240
- Pharmacology 102
- Biological Psychiatry 5
- Rheumatology 26
- Toxicology 10
Countries citing papers authored by David Hägg
This map shows the geographic impact of David Hägg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Hägg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Hägg more than expected).
Fields of papers citing papers by David Hägg
This network shows the impact of papers produced by David Hägg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Hägg. The network helps show where David Hägg may publish in the future.
Co-authors
The 25 scholars most cited alongside David Hägg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 131 | |
| 2 | 2013 | 95 | |
| 3 | 2018 | 82 | |
| 4 | 2019 | 54 | |
| 5 | 2014 | 42 | |
| 6 | 2019 | 26 | |
| 7 | 2020 | 23 | |
| 8 | 2021 | 12 | |
| 9 | 2018 | 11 | |
| 10 | 2021 | 7 | |
| 11 | 2015 | 5 | |
| 12 | 2020 | 3 | |
| 13 | 2022 | 2 | |
| 14 | 2024 | 2 | |
| 15 | Agomelatine and other antidepressants and the risk of acute liver injury (ALI), a pass in four European countries | 2018 | 1 |
| 16 | 2024 | 1 | |
| 17 | 2025 | 0 | |
| 18 | 2025 | 0 |
About David Hägg
David Hägg is a scholar working on Immunology, Pharmacology, Obstetrics and Gynecology, Pharmacology and Urology, having authored 18 papers that have together received 497 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (6 papers), Treatment of Major Depression (4 papers), COVID-19 Impact on Reproduction (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Attention Deficit Hyperactivity Disorder (1 paper), Rheumatoid Arthritis Research and Therapies (1 paper), Menopause: Health Impacts and Treatments (1 paper) and Pregnancy and Medication Impact (1 paper). The work is most often cited by research in Immunology (240 citations), Pharmacology (102 citations), Biological Psychiatry (5 citations), Rheumatology (26 citations) and Toxicology (10 citations). David Hägg has collaborated with scholars based in Sweden, United States and Denmark. Frequent co-authors include Anders Sundström, Marcus Schmitt‐Egenolf, Marie Eriksson, Johan Reutfors, Lena Brandt, Philip Brenner, Allitia DiBernardo, Robert Bodén, Therese M-L Andersson and Marie Linder. Their work appears in journals such as Journal of Affective Disorders, Clinical Epidemiology, PLoS ONE, CNS Drugs and JAAD International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.